XRCC3 Antibody

說明書

中文名稱：

XRCC3兔多克隆抗體
貨號：

CSB-PA004531
規格：

￥1090
圖片：
Western Blot analysis of HepG2 cells using XRCC3 Polyclonal Antibody
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

Uniprot No.：

O43542
基因名：

XRCC3
別名：

CMM6 antibody; DNA repair protein XRCC3 antibody; RAD51 like antibody; X ray repair complementing defective repair in Chinese hamster antibody; X ray repair complementing defective repair in Chinese hamster cells 3 antibody; X ray repair cross complementing protein 3 antibody; X-ray repair cross-complementing protein 3 antibody; XRCC 3 antibody; XRCC3 antibody; XRCC3_HUMAN antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Synthesized peptide derived from the Internal region of Human XRCC3.
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
抗體亞型：

IgG
純化方式：

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
產品提供形式：

Liquid
應用范圍：

WB, IHC, ELISA

推薦稀釋比：

Application	Recommended Dilution
WB	1:500-1:2000
IHC	1:100-1:300
ELISA	1:10000

Protocols：

Western Blotting (WB) Protocol
Immunohistochemistry (IHC) Protocol
ELISA Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA, thought to repair chromosomal fragmentation, translocations and deletions. Part of the RAD21 paralog protein complex CX3 which acts in the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage, CX3 acts downstream of RAD51 recruitment; the complex binds predominantly to the intersection of the four duplex arms of the Holliday junction (HJ) and to junctions of replication forks. Involved in HJ resolution and thus in processing HR intermediates late in the DNA repair process; the function may be linked to the CX3 complex and seems to involve GEN1 during mitotic cell cycle progression. Part of a PALB2-scaffolded HR complex containing BRCA2 and RAD51C and which is thought to play a role in DNA repair by HR. Plays a role in regulating mitochondrial DNA copy number under conditions of oxidative stress in the presence of RAD51 and RAD51C.
基因功能參考文獻：
1. Although XRCC3 plays a role in asthma etiology, the variant XRCC3 genotypes do not serve as practicable predictive markers for asthma risk in Taiwanese. PMID: 30150425
2. Our results indicated a link between ERCC1 rs3212986 and the onset of late gastrointestinal toxicity ..No association was found regarding the XRCC3 rs861539 polymorphism and any clinical toxicity event PMID: 28708208
3. XRCC3 gene SNPs could influence the tumour aggressiveness expressed by tumour grade in hepatocellular carcinoma. PMID: 29895130
4. XRCC3 deleterious variants were identified in breast and ovarian cancer cases. PMID: 29255180
5. hypermethylation of homologous recombination DNA repair genes including RAD51B and XRCC3 is associated with an inflamed phenotype in squamous cell cancers of the head and neck, lung and cervix. PMID: 27683114
6. The combined AA/AA genotype and GG/GA genotype frequencies for rs1799794 and rs709399 polymorphisms were significantly higher in thyroid cancer patients compared to control group when compared with combined AA/GG genotype as reference. PMID: 28490032
7. based on the evidence from the large-scale case-control study and meta-analysis, the rs861539 within XRCC3 gene was associated with the risk of NPC under recessive model. PMID: 27639382
8. our study suggested that the polymorphism of rs861539 in XRCC3 was associated with increased risk of PTC. PMID: 26264616
9. XRCC3-Met allele seems to contribute to the development of OSCC, metastases and more advanced stages in these lesions. PMID: 26742000
10. This meta-analysis suggested that the XRCC3 rs861539 polymorphism was not a risk factor for cutaneous melanoma susceptibility. [meta-analysis] PMID: 26922354
11. XPD Lys751Gln polymorphism may be a risk factor for CCRCC. Regarding the XRCC3 Thr241Met polymorphism, an association with CCRCC was found only in XRCC3 Thr241Met/XPD Lys751Gln combined genotypes. PMID: 26682510
12. XRCC3 T241M polymorphism may constitute a risk factor for hepatocellular carcinoma in the Chinese population (Meta-Analysis) PMID: 26662391
13. the results obtained during this study suggest that rs1799794 in XRCC3 shows strong association with breast cancer development in Saudi females. PMID: 26881229
14. XRCC3 Thr241Met polymorphism is associated with an increased risk of thyroid cancer in the overall population PMID: 26687776
15. XRCC3 rs861539 TT is a potential predictive marker for triple-negative breast cancer in Taiwanese women PMID: 26543082
16. our study firstly reports that XRCC3 Thr241Met gene polymorphism is associated with an elavated risk of osteosarcoma. PMID: 26662447
17. XRCC3 Thr241Met gene polymorphism was associated with increased risk of osteosarcoma PMID: 26617908
18. Our findings demonstrated that the T241M polymorphism in the XRCC3 gene may not be a risk factor for colorectal cancer development. PMID: 26600544
19. The rs861539 and rs3212112 polymorphisms in the XRCC3 gene may influence the risk of glioma development in a Chinese population. PMID: 26400288
20. XRCC3 Thr241Met polymorphism might be associated with breast cancer risk, especially in Asian populations and in patients without family history of breast ca [meta-analysis] PMID: 26498491
21. results indicate that Thr241Met polymorphism was not associated with the development of laryngeal cancer in Turkish population. PMID: 25510985
22. XRCC3 may be a novel radiosensitivity predictor and promising therapeutic target for esophageal squamous cell carcinoma PMID: 26383967
23. XRCC3 deregulation is extensively involved in the chemoresistance mechanisms in rectal cancer patients. PMID: 26023803
24. The T allele (CT and TT genotypes) of XRCC3 rs861539 contributes to increased risk of leiomyoma among Taiwanese women and may serve as a early detection and predictive marker. PMID: 26254358
25. Association between XRCC3 polymorphisms and the risk of radiation-induced normal tissue adverse effects. [meta-analysis] PMID: 26091483
26. XRCC3 gene rs861539 polymorphism was associated with the risk for gastric cancer in Asian populations. PMID: 25973083
27. The XRCC3 genotype and allele frequencies were not significantly different between gastric cancer patients and controls in a North India population. PMID: 25642794
28. XRCC3 Thr241Met polymorphism was associated with increased risk of colorectal cancer. PMID: 25824748
29. XRCC3 gene polymorphism is not correlated with the radiotherapy-based multimodality treatment in rectal cancer. PMID: 25684513
30. the XRCC3 Thr241Met genetic variant is associated with prostate cancer risk. PMID: 25834539
31. CT and TT genotypes of XRCC3 rs861539 were associated with increased lung cancer risk. PMID: 26124335
32. The frequency of heterozygous and homozygous genotype of Thr241Met polymorphism of XRCC3 were significantly higher in Pakistani breast cancer patients. PMID: 25556451
33. The XRCC3 gene polymorphism was not found to be associated with the risk of oral cancer. [Meta-Analysis] PMID: 25556470
34. The Thr241Met polymorphism of XRCC3 was associated with a 16 fold increase in head and neck cancer risk. PMID: 25556492
35. This study displayed a significantly elevated risk for colorectal cancer in individuals with XRCC3 Thr/Met and Met/Met Genotype of about 2.5 times that with the Thr/Thr wild genotype. PMID: 25520078
36. XRCC3 T241M polymorphism may not be a risk factor for lung cancer. PMID: 25501160
37. The T allele of XRCC3 rs861539, interacts with smoking habit in increasing nasopharyngeal carcinoma(NPC) risk, may be an early detection marker for NPC. PMID: 25687493
38. This meta-analysis provides evidence that the RAD51 and XRCC3 polymorphisms are not associated with an increased risk of AML in the total population. PMID: 23978154
39. the aim of this study was to evaluate the clinical response to platinum-based chemotherapy and treatment outcome of gastric cancer patients in the present of ERCC1, ERCC2, NBN, RAD51, and XRCC3 gene polymorphisms. PMID: 25542228
40. Association of DNA repair genes XRCC1 (Arg399Gln), (Arg194Trp) and XRCC3 (Thr241Met) polymorphisms with the risk of breast cancer: a case-control study in Egypt. PMID: 25340946
41. XRCC3 Thr241Met may act as a favorable prognostic indicator for lung squamous cell carcinoma patients. PMID: 23443124
42. This meta-analysis suggests that the T241M polymorphism of the XRCC3 gene confers a weakly increased breast cancer risk. PMID: 25169497
43. There is no clear evidence showing a significant correlation between XRCC3 Thr241Met polymorphism and lung cancer risk in total population and stratified analysis by ethnicity. PMID: 25794597
44. our results did not confirm the hypothesis of a possible role of NBN and XRCC3 SNPs in acute lymphoblastic leukaemia risk. PMID: 25176580
45. there was no association between XRCC3 Thr241Met (rs861539) polymorphism and leukemia risk in the overall population, but significant association between XRCC3 Thr241Met (rs861539) polymorphism and leukemia risk was found in the Asian population. PMID: 24304418
46. Studied the relation between XRCC3 Thr241Met polymorphism and lung cancer susceptibility of populations in East Asia. PMID: 25066399
47. findings have suggested that APE1, XRCC3, XPD, and hOGG1 gene variants could facilitate the development of migraine disease. PMID: 24892639
48. XRCC3 were associated with ovarian cancer risk overall for Caucasians. PMID: 25006581
49. XRCC3 single nucleotide polymorphism and gene frequency in Russians, Tatars and Bashkirs. PMID: 25474887
50. present meta-analysis demonstrates that XRCC3 C18067T polymorphism was not associated with risk of cutaneous melanoma but contributed a decreased risk to both basal cell carcinoma and squamous cell carcinoma PMID: 24454720
顯示更多

收起更多
相關疾?。?/div>
Breast cancer (BC); Melanoma, cutaneous malignant 6 (CMM6)
亞細胞定位：

Nucleus. Cytoplasm. Cytoplasm, perinuclear region. Mitochondrion. Note=Accumulates in discrete nuclear foci prior to DNA damage, and these foci persist throughout the time course of DNA repair.
蛋白家族：

RecA family, RAD51 subfamily
數據庫鏈接：

HGNC: 12830

OMIM: 114480

KEGG: hsa:7517

STRING: 9606.ENSP00000343392

UniGene: Hs.592325

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human